Late Stent Thrombosis After Drug-Eluting Stent Implantation: A Rare Case of Accelerated Neo-Atherosclerosis and Early Manifestation of Neointimal Rupture
![]() |
Yang, Young-June
(Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine)
Kim, Mi-Hyun (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) Kim, Choong-Ki (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) Park, Jun-Beom (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) Oh, Jae-Won (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) Won, Ho-Youn (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) Kim, Byeong-Keuk (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) Hong, Myeong-Ki (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) |
1 | Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23. DOI ScienceOn |
2 | Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350:221-31. DOI ScienceOn |
3 | Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30. DOI ScienceOn |
4 | Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-78. DOI ScienceOn |
5 | Cook S, Ladich E, Nakazawa G, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009;120:391-9. DOI ScienceOn |
6 | Chevalier B, Silber S, Park SJ, et al. Randomized comparison of the Nobori biolimus A9-eluting coronary stent with the Taxus Liberte paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial: phase 2. Circ Cardiovasc Interv 2009;2:188-95. DOI ScienceOn |
7 | Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41. DOI ScienceOn |
8 | Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701-6. DOI ScienceOn |
9 | Lee CW, Kang SJ, Park DW, et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 2010;55:1936-42. DOI ScienceOn |
10 | Nakazawa G, Vorpahl M, Finn AV, Narula J, Virmani R. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imaging 2009;2:625-8. DOI |
11 | Garg S, Sarno G, Serruys PW, et al. The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer. EuroIntervention 2010;6:233-9, doi: 10.4244/. DOI |
![]() |